Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, No. 2 Anzhen Road, Beijing, 100029, China.
J Cardiothorac Surg. 2022 Jun 7;17(1):144. doi: 10.1186/s13019-022-01905-8.
This study was designed to compare early outcomes associated with coronary artery bypass grafting for multi-vessel disease conducted using either minimally invasive or conventional off-pump techniques.
From January 2017 through January 2021, 582 patients with multi-vessel lesion coronary artery disease underwent either minimally invasive cardiac surgery coronary artery bypass grafting (MICS CABG) or conventional off-pump coronary artery bypass grafting (OPCABG) treatment by our team at Anzhen Hospital. Patients in the MICS CABG group were propensity score-matched with those in the OPCABG at a 1:1 ratio (MICS CABG = 172; OPCABG = 172), using epidemiological data, preoperative clinical characteristics, and SYNTAX score as covariates. Perioperative outcomes and 6-month computed tomography angiography findings were compared between these groups.
No significant differences between groups were observed with respect to 30-day postoperative mortality, myocardial infarction, and stroke incidence. Surgical data indicated that the MICS CABG procedure was able to cover all three main arterial territories with a relatively low need for circulatory assistance. The MICS CABG procedure was associated with a longer operative duration, but was also associated with higher postoperative hemoglobin and activities of daily living index values as well as a shorter duration of postoperative hospitalization (P < 0.05). No differences in 6-month graft patency were observed between groups.
MICS CABG is a safe, less invasive alternative to OPCABG when performing complete revascularization provided patients are properly selected, yielding similar in-hospital outcomes and 6-month graft patency rates together with an earlier return of physical function.
本研究旨在比较微创与常规非体外循环冠状动脉旁路移植术治疗多支血管病变的早期结果。
2017 年 1 月至 2021 年 1 月,我院团队对 582 例多支血管病变冠心病患者分别行微创心脏手术冠状动脉旁路移植术(MICS CABG)或常规非体外循环冠状动脉旁路移植术(OPCABG)治疗。采用倾向性评分匹配法(1:1),根据流行病学资料、术前临床特征和 SYNTAX 评分,将 MICS CABG 组患者与 OPCABG 组患者进行匹配(MICS CABG=172;OPCABG=172)。比较两组患者的围手术期结果和 6 个月计算机断层血管造影(CTA)结果。
两组患者在 30 天术后死亡率、心肌梗死和卒中发生率方面无显著差异。手术数据表明,MICS CABG 术式可覆盖所有三个主要动脉区域,且对循环辅助的需求相对较低。MICS CABG 术式的手术时间较长,但术后血红蛋白和日常生活活动指数值较高,术后住院时间较短(P<0.05)。两组患者 6 个月时的桥血管通畅率无差异。
在适当选择患者的情况下,MICS CABG 是 OPCABG 的一种安全、微创的替代方法,可实现完全血运重建,其住院期间的结局和 6 个月时的桥血管通畅率与 OPCABG 相似,且更早恢复身体功能。